Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for mycophenolate mofetil, the generic immunosuppressant, via Teva Pharmaceuticals USA, Inc. This ac…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil submitted by Mylan Pharmaceuticals Inc. The action updates the product's l…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
A Phase 2 safety and efficacy study of belimumab (LymphoStat-B) in systemic lupus erythematosus has completed with results posted.
-
FDA approval · 2012-07-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., resulting in changes to the approved …
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis [Phase 2, Phase 3]
Clinical trial update on the efficacy and safety of Tripterygium wilfordii for lupus nephritis across Phase 2 and Phase 3 studies. The curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus [Phase 2]
Phase 2 clinical trial evaluating epratuzumab for systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease [Phase 2]
Open-label Phase 2 trial of epratuzumab in serologically-positive systemic lupus erythematosus with active disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus [Phase 1]
Phase 1 study assessing the safety and tolerability of multiple intravenous doses of MEDI-545 in adults with systemic lupus erythematosus ha…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Evaluation of the Influence of Food Regimen on Oshadi D Absorption [NA]
A completed clinical trial assessing how different food regimens affect the absorption of Oshadi D in systemic lupus erythematosus patients.
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
A completed clinical trial evaluating genotype-guided, personalized dosing of cyclophosphamide for systemic lupus erythematosus, aiming to o…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) [Phase 3]
A Phase 3 trial of epratuzumab in systemic lupus erythematosus sponsored by UCB Pharma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Phase 2, Phase 3]
A Phase 2/3 efficacy and safety study of abatacept for lupus nephritis in systemic lupus erythematosus has been terminated, with results pos…
-
CLINICAL_TRIALS withdrawal · 2012-04-30Clinical Trial Update: Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus [Phase 2]
A Phase 2 trial of R935788 for systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) [Phase 2]
A Phase 2 pharmacokinetics study of epratuzumab in systemic lupus erythematosus has been terminated.
-
FDA approval · 2012-03-30FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for BENLYSTA (belimumab) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS withdrawal · 2012-03-30Clinical Trial Update: Doxycycline Outcomes in Lupus Erythematosus [Phase 4]
A Phase 4 trial evaluating doxycycline in patients with lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS research · 2012-03-21Clinical Trial Update: Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
A retrospective analysis assessing the safety and efficacy of hydroxychloroquine in immune thrombocytopenia, including cases with systemic l…
-
CLINICAL_TRIALS research · 2012-02-20Clinical Trial Update: Coping Skills Training (CST) for Children With Chronic Health Conditions [Phase 2]
This update notes the completion of a Phase 2 clinical trial of Coping Skills Training for children with chronic health conditions, includin…
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus [Phase 4]
Phase 4 clinical trial investigating steroid-induced osteoporosis in patients with systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus [Phase 2]
Phase 2 clinical trial evaluating targeted strategies with B-cell depletion therapy, alone or in combination, for systemic lupus erythematos…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) [Phase 1]
Phase 1 study evaluating AGS-009 in systemic lupus erythematosus has completed its status.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Vitamin D Supplementation in Systemic Lupus Erythematosus
A completed clinical trial from Assistance Publique - Hôpitaux de Paris evaluated vitamin D supplementation in patients with systemic lupus …
-
CLINICAL_TRIALS research · 2011-11-15Clinical Trial Update: Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
This clinical trial update describes a study evaluating ultrasound of the hands in patients with systemic lupus erythematosus, with rheumato…
-
CLINICAL_TRIALS withdrawal · 2011-11-08Clinical Trial Update: Study of Epratuzumab in Systemic Lupus Erythematosus [Phase 3]
A Phase 3 study of the monoclonal antibody epratuzumab for systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS research · 2011-10-27Clinical Trial Update: Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)
A clinical study investigates membrane polyunsaturated fatty acid content in fibromyalgia and systemic lupus erythematosus. The current stud…